Abstract Background: Aortofemoral bypass(AFB), iliofemoral bypass(IFB), and aortoiliac endarterectomy(AIE) are the three most common techniques for anatomical open surgical revascularisation for patients with aorto-iliac occlusive disease(AIOD), but the optimal method of reconstruction is unknown. Aims: To review and compare mortality, morbidity and short-and long-term patency rates for AFB, IFB and AIE in patients with AIOD reported in the English language literature Methods: A MEDLINE(1970e2007) and Cochrane Library search for articles relating to AFB, IFB, AIE and AIOD was undertaken. Studies were included if: a) patency rates based on life-tables were available, and b) patient/study characteristics were reported. Results: 29 studies(5738 patients) for AFB, 11 studies(778 patients) for IFB and 11 studies(1490 patients) for AIE were included. Operative mortality was 4.1% for AFB, 2.7% for IFB and 2.7% for AIE (p < 0.0001). Systemic morbidity was 16.0% for AFB, 18.9% for IFB and 12.5% for AIE (p < 0.05). Overall 5-year primary patency rates were 86.3%, 85.3% and 88.3% for AFB, IFB and AIE, respectively (p Z NS). Conclusion: Aorto-iliac endarterectomy was associated with significantly lower peri-operative morbidity and mortality rates compared with bypass grafting. All three techniques were equally effective in terms of long-term patency. ª
Introduction
Open surgical reconstruction represents the evidencebased treatment of choice for Trans-Atlantic Inter-Society Consensus (TASC) II type-C and D aortoiliac lesions. 1, 2 Since the pioneering work by dos Santos in the area of aortoiliac endarterectomy, a variety of anatomical and extra-anatomical open surgical arterial reconstructions have been described for the management of patients with symptomatic aorto-iliac occlusive disease (AIOD). 3 The most widely utilised anatomical open surgical reconstructions are: aortofemoral bypass (AFB), iliofemoral bypass (IFB) and aortoiliac endarterectomy (AIE). Descending thoracic aortofemoral bypass (DTAF) has also been described but is predominantly reserved for patients in which the aforementioned reconstructions are unsuitable. 4, 5 Bypass grafting is widely accepted as the anatomical procedure of choice for AIOD and aortoiliac endarterectomy has fallen out of favour with the majority of vascular surgeons. To date, no comparative study has been undertaken to determine the optimal method of anatomical reconstruction for AIOD.
The aims of this study were a) to review and compare the short-and long-term outcomes of AFB, IFB, AIE and DTAF for the treatment of AOID and b) to provide an evidence-based benchmark with which to compare the results of established and evolving endovascular therapies.
Materials and methods
We performed a MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) databases search looking for English language articles relating to AFB, IFB, AIE, DTAF and AIOD between January 1970 and August 2007. The terms aorta, iliac artery and aortoiliac were included amongst others. These were linked with terms such as reconstruction, revascularisation, bypass, endarterectomy, atherosclerosis and occlusion. Further articles were identified by following MEDLINE links, by cross-referencing from the reference lists of major articles and by following citations for these studies. Figure 1 Cumulative patency for patients who underwent Aortofemoral Bypass, Iliofemoral Bypass and Aortoiliac Endarterectomy. Studies reporting long-term primary patency data following open anatomical repair of aorto-iliac occlusive disease were included if a) the results for patients with AIOD were reported separately; b) the primary patency data were presented in a life-table format that met the Society for Vascular Surgery/International Society for Cardiovascular Surgery ISCVS/SVS criteria, using yearly or smaller intervals, or such life-tables could be reconstructed from the presented data; c) the patient demographics and study characteristics were reported in sufficient detail to allow for adjustment for the case-mix and the reporting methods in the analysis; and d) the study cohort was greater than 10 patients. In instances whereby more than one publication from the same cohort was available, we 1976e1990  26  52  54  59  65  35  26  0  0  13  Brewster   52   1963e1977  341  657  27  58  56  44  316  25  0  29  Couch   14   1972e1985  111  208  e  e  68  32  97  14  0  e  Dunn   15   1968e1979  192  384  28  60  64  36  192  0  0  3  Friedman   16   1986e1989  60  120  37  68  67  33  60  0  0  58  Harris   18   1979e1984  200  377  26  58  71  29  177  23  0  0  Jackson   21   1992e2003  111  222  37  49  42  58  111  0  0  0  Jensen   22   1979e1986  56  112  68  45  80  20  40  2  14  33  Johnson   23   1965e1975 88 included only the most recent publication unless; a) evidence was available that the patient population did not overlap and b) the most recent publication was unsuitable for data extraction or a more complete data set was available from previous publications.
A proforma was used to extract the data from the articles; these data included study design, reporting methods, patient risk factors, operative morbidity/mortality and primary and secondary patency rates. The patient demographics, risk factors, and short-and long-term outcomes used in this study were previously identified as relevant factors by other studies. 6, 7 The definition of 'peri-operative' period varied between studies, but was generally defined as within 30 days of the index intervention. Thus, we defined operative mortality as death within this period. A systemic complication was defined as a dysfunction of one or more major organ systems within 30 days of the index procedure. A local complication was defined as a non-fatal complication limited to the site of operation and occurring within 30 days of the index procedure. Graft-related complication was defined as all non-fatal damage or disease related to the graft including intervention failures (i.e. failed procedures). For AIE, as no prosthetic graft was used, we only collected data for intervention failures (i.e. failed endarterectomy).
In order to calculate primary patencies, data from the studies needed to be presented or able to be converted to a life-table format. In 49% of the studies (22/45), patency data were presented in life-table formats. In the remaining studies, life-tables were reconstructed from survival curves with sufficient data. We assumed that the lowest point at each time interval in a survival curve represented the patency rate of the observed unit at that time.
Patient demographics and risk factors from each study were pooled for analysis. Statistical comparison of aggregated patency data was based on Cox proportional hazard regression. Spearman correlation was used to quantify the association of each of the outcomes with patient demographics and risk factors. Life-table analysis was carried out. A covariate, symptomatic status of patients prior to interventions, was included for further sub-analysis using methodology previously described by Hunink and Wong. 8 This methodology allows the combination of failure-time data from various sources, adjusting for differences in case-mix among studies. It is based on the proportionalhazards model and the actuarial life-table approach. Twosided p-values are reported and differences in results were considered to be ''statistically significant'' if the p-value was <0.05. Microsoft Excel 2000 and the statistical package Graphpad Prism â version 5.00 were utilised for analysis.
Results 590 studies were identified, 331 (56%) studies were excluded from their abstracts alone, resulting in 259 (44%) articles being retrieved. A further 214 (36%) publications were excluded for various reasons. Thus, 45 (8%) articles were included in the process of data extraction and analysis (Fig. 3) . 4,5,9e51 Of the 45 studies included, 29 studies (5738 patients) included data for AFB, 11 studies (778 patients) for IFB and 11 studies (1490 patients) for AIE. Two studies (174 patients) were identified for DTAF. 4, 5 Six studies included data for both AFB and IFB and one study included data for AFB, IFB and AIE 19, 29, 34, 41, 49, 52 (Tables 1e7). More patients underwent AFB than AIE or IFB. The majority of these patients were male (76.5%) and their main indication for intervention was intermittent claudication (IC). There were significant inter-study differences for patient demographics and risk factors: male:female ratio (p < 0.02), smoking history, diabetes, ischaemic heart disease (IHD) and hypertension (HT) (all p < 0.0001). The AFB cohort had the highest proportion of patients with diabetes and HT while the IFB cohort had the highest proportion of patients with IHD and CLI as the indication for surgery. The AIE cohort had the highest proportion of smokers. There were insufficient data to analyse mean age between the cohorts ( Table 1 ).
The operative mortality rate for AFB, IFB and AIE was reported in 93% (42/45) of the studies and was 4.1%, 2.7% and 2.7%, respectively (p < 0.0001). Systemic morbidity was reported in 56% (25/45) of studies, local morbidity in 51% (23/45) and graft-related morbidity/failed endarterectomy in 71% (32/45). The systemic morbidity rate was 16% for AFB, 18.9% for IFB and 12.5% for AIE (p < 0.0001). The local morbidity rate was 6.3% for AFB, 5.7% for IFB and 3.4% for AIE (p < 0.003). There was no correlation between operative mortality and systemic or local morbidity, and patient demographics or risk factors. The graft-related morbidity/intervention failure rates for AFB, IFB and AIE were 3.1%, 4.2% and 3.8%, respectively (p Z 0.31). For AFB, 8 studies (2619 patients) quoted graft infection rates and the combined rate was calculated to be 0.7%. As for IFB, only 3 studies (237 patients) mentioned graft infection rates specifically and was calculated to be 0.4%. There are insufficient data to analysis the severity of these infections.
Patency criteria were defined in 58% (26/45) of studies and these varied from clinical symptomatology/examination to radiological assessment. All studies except one 23 
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reported primary patency data. Although Johnson et al. 23 reported secondary patency in isolation we were able to reconstruct a primary patency life-table from the published data. The 5-year primary patency rates were 86.3%, 85.3% and 88.3% for AFB, IFB and AIE, respectively (p Z 0.12).
Outcomes following AFB, IFB and AIE were further subanalysed according to patient clinical presentation. The 5-year primary patency rates for patients with IC were 89.8%, 86.7% and 90.8% for AFB, IFB and AIE, respectively (p Z 0.07) and, for patients with CLI, were 79.8%, 74.1% and 81.7% for AFB, IFB and AIE, respectively (p Z 0.06). There was a significant difference in 5-year patency rates for patients with IC and CLI (p < 0.0001) ( Tables 1, 8e10 and Figs. 1 and 2) .
The pooled results were further analysed according to the decade during which the studies were undertaken. For AFB, the 5-year patency in studies carried out during the 1970s was 88.4% and gradually decreased to 76.1% for studies carried out after the millennium (p Z 0.03). For IFB, data were only available for studies carried out in the 1980s and 1990s and this also demonstrated a fall in 5-year patency rate from 88.6% to 73.1% (p Z 0.001). The results were not statistically significant for AIE.
The small number of patients who underwent DTAF precluded reliable statistical comparison with the other three techniques. Operative mortality for DTAF was 4.6%. Systemic and local morbidities were not reported in the published studies but graft-related morbidity was 4.5%. The 5-year primary patency rate for DTAF was 79.6% (Table 11) .
Discussion
The present review represents more than 35 years of experience in anatomical open surgical revascularisation for patients with symptomatic AIOD and, to our knowledge, the first comparative analysis of major outcomes following aortofemoral bypass, iliofemoral bypass and aortoiliac endarterectomy.
The principal finding of the present study is that AIE appears to be associated with significantly lower operative mortality (2.7%) and systemic (12.5%) and local complication rates (3.3%) compared with the two bypass procedures. The reason for this finding is not obvious from the data collected and presented but intuitively one would assume that patient selection is important with AIE being utilised predominantly for localised aortoiliac disease and AFB and IFB may be used for more extensive disease. 53 All three techniques were equally effective in terms of 5-year primary patency rates. There was a trend toward improved 5-year patency rates for both IC and CLI following AFB and AIE when compared to IFB.
Several studies have compared prosthetic bypass with endarterectomy for the treatment of AOID with conflicting results. Some authors have reported higher morbidity and lower patency rates for AIE 52, 54 while others have demonstrated lower morbidity and comparable long-term outcomes when compared with bypass in appropriately selected patients. 53, 55, 56 There are no trials directly comparing AFB and IFB, and those observational studies that exist are inconclusive with some reporting comparable outcomes while others report poorer long-term outcomes Surgical Management of Atherosclerotic Aorto-Iliac Occlusive Diseasewith IFB. 17, 25, 41, 57 However, IFB is consistently reported as being less traumatic and requiring shorter exposure time when compared to AFB. 13, 58 As expected, patients presenting with CLI demonstrated poorer 5-year patency rates when compared with patients with IC irrespective of reconstruction. 7, 34, 59, 60 Unfortunately, there was insufficient breakdown of published data to perform sub-analysis according to patient characteristics, risk factors and operative risks.
Interestingly, when data were compared by decade of publication there was a decrease in patency rates for AFB and IFB over time. Previous studies have shown either no statistical difference or improved patency over time. 7, 52, 61 When each of the patient characteristics were analysed there were statistical differences over time, but no obvious trend to explain why patency rates fell with time. For AFB, patients were younger, more presented with CLI, systemic morbidity fell, local morbidity increased and operative Table  Primary mortality remained unchanged. These results are similar to those observed by de Vries and colleagues with the exception that we did not reveal a statistically significant change in mortality rate. 7 As for IFB, patients were similar in age, less likely to have CLI, systemic morbidity rose, and minor morbidity and mortality remained unchanged. A factor to consider when analysing these results is that there may be overlaps between decades when the operations were carried out. We aggregated our results depending on when the studies were published.
The majority of these studies are retrospective observational studies with the exception of two prospective observational studies 9, 31 and 3 randomised trials. 16, 30, 42 As none of the patients nor surgeons involved in any of the studies were blinded, these data may be biased. Although it is difficult to minimise problems such as selection, performance and detection bias as patients selected into the studies involved were determined by the authors of the studies, we attempted to minimise the effect by selecting studies with larger groups (i.e. studies involving more than 10 patients). We further attempted to minimise analysis bias by carrying out our statistical analysis by an external statistician with no prior knowledge in any of the techniques or preferences of the other authors.
Nearly half of the studies did not mention the types of grafts used in their studies. The majority of the remainder used a combination of Dacron and PTFE, while others used only Dacron, PTFE or superficial femoral vein. Amongst the studies that use a combination of graft materials, only 3 studies provided sufficient data to allow different types of grafts used to be separately analysed (Tables 12e14) . 16, 42, 48 Thus further analysis on how different types of grafts affect patency were not carried out.
Only two studies reporting results for DTAF were identified as suitable for data extraction. 4, 5 As one might expect, these data suggest that DTAF is associated with higher operative mortality and graft-related complication rates and lower 5-year patency rate than the other three techniques. However, as DTAF was not included in the statistical analysis it is difficult to draw robust conclusions.
In conclusion, the present review demonstrates that AIE is associated with significantly lower morbidity and mortality rates and equivalent patency rates to AFB and IFB. In appropriately selected patients AIE remains an acceptable, relatively low-risk and robust reconstruction. In patients who do not have a pattern of disease amenable to endarterectomy, AFB or IFB can provide equally effective long-term outcomes albeit with higher peri-operative risk. These data provide an important benchmark with which to compare the short-and long-term results of emerging endovascular interventions. Table  Priamry 
